Financial Results for Dec 31, 2012
Merck Ltd has informed BSE about the Financial Results for the period ended December 31, 2012.30-01-2013
Financial Results for Dec 31, 2012
Merck Ltd has informed BSE about the Financial Results for the period ended December 31, 2012.Board to consider Dividend
Merck Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 30, 2013, to consider and approve the Audited Financial Results for the year ended December 31, 2012 and to recommend dividend, if any.Limited Review for Sep 30, 2012
Merck Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended September 30, 2012.Outcome of Board Meeting
Merck Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 22, 2012 appointed Mr. Narayanaswamy Krishan as a Whole time director of the Company w.e.f. October 01, 2012 and Dr. Mannheimer, Peter-Ulrich as a Director of the Company in place of Mr. Timothy Kneen.Financial Results for Sep 30, 2012
Merck Ltd has informed BSE about the Financial Results for the period ended September 30, 2012.Board Meeting on Oct 22, 2012
Merck Ltd has informed BSE that upon attaining superannuation, Mr. R. L. Shenoy has resigned from the office of director and whole time director of the Company with effect from September 30, 2012. The Board of Directors of the Company at its ensuing meeting on October 22, 2012 will consider the appointment of an additional director and executive director in place of Mr. Shenoy.Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Homi C H Bhabha has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Merck Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Merck Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992